ClinicalTrials.gg
RecruitingNCT06534385Updated Feb 27, 2025

The Clean Air Study: HEPA Purifiers to Improve Indoor Air Quality and Health in Rural Alaska Homes

An interventional study of Air purifier in Air Pollution, Indoor, sponsored by Alaska Native Tribal Health Consortium. Recruiting at 1 site in United States. Open to participants aged Up to 5 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-27.

Sponsored by Alaska Native Tribal Health Consortium · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Nov 2024; still recruiting 1 year 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
Up to 5 Years
Sex
All
01

Study summary

Alaska Native children experience a high burden of respiratory disease, especially those in the Yukon-Kuskokwim (YK) Delta. Studies have shown that things like wood stove use, poor ventilation, and indoor tobacco smoke exposure can lead to poor indoor air quality inside the children's homes. This leads to more frequent and more severe respiratory infections in children.

In the Yukon-Kuskokwim (YK) Delta, it's common for homes to have exposure to woodstoves and tobacco use. Both of these activities affect indoor air quality in homes. We know that high efficiency particulate air (HEPA) purifiers can reduce particulate matter and make air quality better. One way that we measure air quality is through particulate matter (PM2.5). One of the few studies that looked at this in the YK Delta found that PM2.5 levels that were nearly twice as high as homes with woodstoves in other states. We believe it is important to reduce the PM2.5 in YK Delta homes. However, the few studies that looked at HEPA purifiers in rural Alaska did not include homes where smokers lived.

We know that breathing air with PM2.5 harms the lungs. We also know that HEPA filters can reduce PM2.5, which can mean reducing cough and wheeze in people with chronic lung conditions. We want to learn how HEPA filters work in homes with woodstoves or where a smoker lives, as it's likely these homes may have more PM2.5 than other homes. We expect that using HEPA filters will make the indoor air better and will mean decreased respiratory symptoms.

We plan to include 15 households with a child less than 5 years old in the family. Households that join will be asked to:

  • Set up study equipment in their homes.
  • Run the study equipment for 12 weeks and do a weekly report of child's respiratory symptoms by phone or text.
  • Return the air-quality monitor equipment to the study team and keep the HEPA filters.
Read the detailed description

When a child has a pulmonology visit, the nurse will give the family a study flyer and invite them to learn more about the study. Participants that complete the informed consent process will be asked to: set up study equipment in their homes, operate the study equipment and do a weekly report of the child's respiratory symptoms for 12 weeks, and return the air monitoring equipment to the study team.

02

Conditions studied

  • Air Pollution, Indoor
03

In context

Lead sponsor

Alaska Native Tribal Health Consortium is the lead sponsor of 5 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 5 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Alaska Native participants residing in homes where woodstoves are used for heat or a smoker resides in the home.

Exclusion criteria

Exclusion Criteria:

  • Plan to move homes during the study period.
  • Using HEPA air purifiers (other than the ones provided by the study).
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Single group

    Participants receive HEPA purifiers and air monitoring equipment to operate daily for 12-weeks.

    Device: Air purifier

Interventions

  • DeviceAir purifier

    Winix HEPA air purifier

06

What researchers measure

Primary outcomes

  1. Indoor particulate matter (PM2.5) concentrations

    Mean weekly home indoor particulate matter (PM2.5) concentrations

    Time frame: 12-weeks

Secondary outcomes

  1. Reported symptom-free days

    paired analysis of mean symptom-free days with no reported respiratory symptoms

    Time frame: 12-weeks

07

Study locations

1 of 1 sites recruiting
  • Yukon Kuskowkim Health Corporation
    Bethel, Alaska 99559, United States
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2024 (actual). Primary completion is estimated for Apr 2026, 16 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 30, 2024
First posted
Aug 2, 2024
StartActual
Nov 25, 2024
Primary completionEst.
Apr 1, 2026
CompletionEst.
Apr 1, 2026
Last update
Feb 27, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06534385
Lead sponsor
Alaska Native Tribal Health Consortium
Responsible party
Sponsor
First posted
Aug 2, 2024
Start date
Nov 25, 2024
Primary completion
Apr 1, 2026 (estimated)
Completion
Apr 1, 2026 (estimated)
Last update
Feb 27, 2025

Study contacts

Jennifer Dobson, MPH
Contact
jddobson@anthc.org
9075453241

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion